Comparison of 2 drugs (ropivacaine and bupivacaine) in spinal anaesthesia for hernia surgeries.

Comparison of intrathecal hyperbaric Ropivacaine 0.75% with hyperbaric Bupivacaine 0.5% for inguinal hernia repair: A randomized double-blind comparative study - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057724

Enrollment

Registered

2023-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: comparison between intrathecal hyperbaric Ropivacaine and hyperbaric Bupivacaine: Intrathecal hyperbaric Ropivacaine (0.75%) 2.5ml Intrathecal hyperbaric Bupivacaine (0.5%) 2.5ml Contro

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I & II Undergoing elective unilateral inguinal hernia surgeries under sunarachnoid block

Exclusion criteria

Exclusion criteria: Patient not willing to participate in the study Patient with contraindication to spinal anaesthesia Patient allergic to any drug Failure of spinal anaesthesia cases in which general anaesthesia will be required

Design outcomes

Primary

Measure	Time frame
Duration of sensory blockTimepoint: Upto 3 Hours postoperatively	—

Secondary

Measure	Time frame
Onset of sensory & motor block duration of motor block haemodynamic parameter complications if anyTimepoint: Upto 24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Astha Negi

Rabindranath Tagore Medical College, Udaipur

dr_ikumari@hotmail.com9414176760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026